Literature DB >> 19932135

The antimicrobial peptides derived from chromogranin/secretogranin family, new actors of innate immunity.

Peiman Shooshtarizadeh1, Dan Zhang, Jean-François Chich, Claire Gasnier, Francis Schneider, Youssef Haïkel, Dominique Aunis, Marie-Hélène Metz-Boutigue.   

Abstract

Chromogranins/secretogranins are members of the granin family present in secretory vesicles of nervous, endocrine and immune cells. In chromaffin cells, activation of nicotinic cholinergic receptors induces the release, with catecholamines, of bioactive peptides resulting from a natural processing. During the past decade, our laboratory has characterized new antimicrobial chromogranin-derived peptides in the secretions of stimulated bovine chromaffin cells. They act at the micromolar range against bacteria, fungi, yeasts, and are non-toxic for the mammalian cells. They are recovered in several biological fluids involved in defence mechanisms (human serum, neutrophil secretions and saliva). These new antimicrobial peptides demonstrate the major role of the adrenal medulla in innate immunity. In this review we focus on the antimicrobial peptides derived from human and bovine chromogranin A (CGA), chromogranin B (CGB) and secretogranin II (SGII) emphasizing their direct action against pathogens and their effects on immune cells.
Copyright © 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19932135     DOI: 10.1016/j.regpep.2009.11.014

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  35 in total

Review 1.  The extended granin family: structure, function, and biomedical implications.

Authors:  Alessandro Bartolomucci; Roberta Possenti; Sushil K Mahata; Reiner Fischer-Colbrie; Y Peng Loh; Stephen R J Salton
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

2.  The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.

Authors:  Stephanie J Soscia; James E Kirby; Kevin J Washicosky; Stephanie M Tucker; Martin Ingelsson; Bradley Hyman; Mark A Burton; Lee E Goldstein; Scott Duong; Rudolph E Tanzi; Robert D Moir
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

Review 3.  Crosstalk at the mucosal border: importance of the gut microenvironment in IBS.

Authors:  Lena Öhman; Hans Törnblom; Magnus Simrén
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-12-02       Impact factor: 46.802

4.  Editorial: fecal granins in IBS: cause or indicator of intestinal or colonic irritation?

Authors:  Michael Camilleri
Journal:  Am J Gastroenterol       Date:  2012-03       Impact factor: 10.864

Review 5.  Chromogranins: from discovery to current times.

Authors:  Karen B Helle; Marie-Helene Metz-Boutigue; Maria Carmela Cerra; Tommaso Angelone
Journal:  Pflugers Arch       Date:  2017-09-05       Impact factor: 3.657

6.  Differential Reovirus-Specific and Herpesvirus-Specific Activator Protein 1 Activation of Secretogranin II Leads to Altered Virus Secretion.

Authors:  Alicia R Berard; Alberto Severini; Kevin M Coombs
Journal:  J Virol       Date:  2015-09-16       Impact factor: 5.103

Review 7.  Gut hormones: emerging role in immune activation and inflammation.

Authors:  W I Khan; J E Ghia
Journal:  Clin Exp Immunol       Date:  2010-04-09       Impact factor: 4.330

Review 8.  Recent developments in the pathophysiology of irritable bowel syndrome.

Authors:  Magdy El-Salhy
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

9.  Phosphopeptidomics Reveals Differential Phosphorylation States and Novel SxE Phosphosite Motifs of Neuropeptides in Dense Core Secretory Vesicles.

Authors:  Christopher B Lietz; Thomas Toneff; Charles Mosier; Sonia Podvin; Anthony J O'Donoghue; Vivian Hook
Journal:  J Am Soc Mass Spectrom       Date:  2018-03-19       Impact factor: 3.109

Review 10.  Is irritable bowel syndrome an organic disorder?

Authors:  Magdy El-Salhy; Doris Gundersen; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.